Overview
Mark Murphy practices in Dublin, Ireland. Mr. Murphy is rated as an Advanced expert by MediFind in the treatment of Alpha-1 Antitrypsin Deficiency (AATD). His top areas of expertise are Emphysema, Subcutaneous Emphysema, Alpha-1 Antitrypsin Deficiency (AATD), and Chronic Obstructive Pulmonary Disease (COPD).
His clinical research consists of co-authoring 32 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles in the study of Alpha-1 Antitrypsin Deficiency (AATD).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- EmphysemaMr. Murphy isDistinguished. Learn about Emphysema.
- Advanced
- Alpha-1 Antitrypsin Deficiency (AATD)
- Chronic Obstructive Pulmonary Disease (COPD)
- Subcutaneous EmphysemaMr. Murphy isAdvanced. Learn about Subcutaneous Emphysema.
- Experienced
- Acute Respiratory Distress Syndrome (ARDS)
- COVID-19Mr. Murphy isExperienced. Learn about COVID-19.
- Cystic FibrosisMr. Murphy isExperienced. Learn about Cystic Fibrosis.
- Diabetic RetinopathyMr. Murphy isExperienced. Learn about Diabetic Retinopathy.
- Severe Acute Respiratory Syndrome (SARS)